InsiderTrades

Form 4 for FENC FENNEC PHARMACEUTICALS INC.

Accepted 2024-04-22 00:00:00 ET · period of report 2024-04-19 · accession 0001415889-24-011336 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-04-22 2024-04-19+ FENC Haigh Adrian COO S - Sale+OE $9.33 -44.4K 0 -100% -$414.7K
DM 2024-04-22 2024-04-19+ FENC Haigh Adrian COO M - OptEx $2.31 +44.4K 22.2K New +$102.7K
DM 2024-04-22 2024-04-19+ FENC Haigh Adrian COO M - OptEx $2.31 -44.4K 382.5K -10% -$102.7K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Shares 2024-04-22 S D 22,223 $9.32 0 D — — (F4) Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
2 Common Common Shares 2024-04-22 M A 22,223 $2.31 22,223 D — — (F3) Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
3 Common Common Shares 2024-04-19 M A 22,222 $2.31 22,222 D — — (F1) Shares acquired pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
4 Common Common Shares 2024-04-19 S D 22,222 $9.34 0 D — — (F2) Shares disposed pursuant to a 10b5-1 plan dated August 17, 2023.
5 Derivative Option 2024-04-22 M D 22,223 $2.31 360,246 D $2.31 · 2014-04-25 to 2024-04-25 22,223 Common Shares (F6) Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023.
6 Derivative Option 2024-04-19 M D 22,222 $2.31 382,469 D $2.31 · 2014-04-25 to 2024-04-25 22,222 Common Shares (F5) Represents option exercise pursuant to a 10b5-1 plan dated August 17, 2023.